These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23453261)

  • 1. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
    Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
    Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the trends in HIV and hepatitis C prevalence amongst injecting drug users in different settings--implications for intervention impact.
    Vickerman P; Martin NK; Hickman M
    Drug Alcohol Depend; 2012 Jun; 123(1-3):122-31. PubMed ID: 22138540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Semaan S
    Am J Public Health; 2011 Jul; 101(7):1277-83. PubMed ID: 21566021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
    Frederick T; Burian P; Terrault N; Cohen M; Augenbraun M; Young M; Seaberg E; Justman J; Levine AM; Mack WJ; Kovacs A
    AIDS Patient Care STDS; 2009 Nov; 23(11):915-23. PubMed ID: 19877800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV and HIV infection and co-infection: injecting drug use and sexual behavior, AjUDE-Brasil I Project.
    Zocratto KB; Caiaffa WT; Proietti FA; Carneiro-Proietti AB; Mingoti SA; Ribeiro GJ;
    Cad Saude Publica; 2006 Apr; 22(4):839-48. PubMed ID: 16612437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission?
    Cruciani M; Wiessing L; Serpelloni G; Genetti B; Andreotti A; Iulia C; Zermiani M; Suligoi B
    BMC Infect Dis; 2015 Apr; 15():201. PubMed ID: 25925747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.
    Zhou YH; Yao ZH; Liu FL; Li H; Jiang L; Zhu JW; Zheng YT
    PLoS One; 2012; 7(8):e42937. PubMed ID: 22916185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
    Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
    Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
    Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
    Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
    J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.